PATENT CLAIM ANALYSIS

Application Number: 16233346
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides compositions and methods for delivery to a lung tissue comprising a small interfering RNA (siRNA) capable of inhibiting expression of a gene, and a surfactant. In one aspect, a non-polymeric methods composition comprising a small interfering RNA (siRNA) capable of inhibiting expression of a gene, and a surfactant is disclosed. In other aspects, a method of inhibiting gene expression in a lung of a subject in need thereof and treating bronchopulmonary dysplasia in a lung of a subject also disclosed. The methods comprise administering a therapeutically effective amount of a non-polymeric composition to the lung of the subject, wherein the non-polymeric composition comprises a small interfering RNA (siRNA) capable of inhibiting expression of a gene, and a surfactant.

Claim (Index 20):
The method of  claim 13  further comprising assessing dysregulated vascularization in the lung.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 98.0
- Lexical Diversity: 2.55556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11799225', '14761083', '13497226', '15129956', '11088691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7338507906762799
- 35 USC 102 Novelty (BERT): 0.5094871946976467
- Combined Prediction Score: 0.7114144310784166
- Mean Citation Score: 233.40571
- Max Citation Score: 237.01128
- Similarity Product: 140.06845848658563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test